Sustained drug-relase particles and process for producing the same

Details for Australian Patent Application No. 2004251541 (hide)

Owner Otsuka Pharmaceutical Co., Ltd.

Inventors Tomohira, Yuso

Agent Freehills

Pub. Number AU-B-2004251541

PCT Pub. Number WO2005/000312

Priority 2003-184040 27.06.03 JP

Filing date 17 June 2004

Wipo publication date 6 January 2005

Acceptance publication date 4 March 2010

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 31/522 (2006.01)

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2005/000312 Priority application(s): WO2005/000312

4 March 2010 Application Accepted

  Published as AU-B-2004251541

29 April 2010 Application for Amendment

  The nature of the amendment is: Amend the invention title to read Sustained drug-release particles and process for producing the same. Address for service in Australia - Freehills Patent & Trade Mark Attorneys Level 43 101 Collins Street Mebourne VIC 3000

12 August 2010 Amendment Made

  The nature of the amendment is: Amend the invention title to read Sustained drug-release particles and process for producing the same 2005

12 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251549-Composition for external use

2004251536-Serum cholesterol lowering agent or preventive or therapeutic agent for atherosclerosis